基于 5 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
Discover the full record of transactions filed by Ng George K. Insider active across 1 company, notably Processa Pharmaceuticals, Inc.. In total, 10 reports have been published. Breakdown: 7 buys · 0 sell. Total volume traded: €115k. Activity tracked since 10 October 2023. The latest transaction was disclosed on 30 April 2026 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
Ng George K is a declarant linked to Processa Pharmaceuticals, Inc., where he is Chief Executive Officer. The record shows 10 filings in total, and across the 10 most recent sampled filings the transactions are acquisitions, with EUR 114648 of purchases and EUR 0 of sales between 2023-10-10 and 2026-08-11.